BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND KRAS, C-K-RAS, 3845, P01116, NS3, KI-RAS, KRAS2, K-RAS4A, K-RAS2A, K-RAS4B, KRAS1, K-RAS2B, RASK2 AND Treatment
266 results:

  • 1. Focal adhesion kinase-YAP signaling axis drives drug-tolerant persister cells and residual disease in lung cancer.
    Haderk F; Chou YT; Cech L; Fernández-Méndez C; Yu J; Olivas V; Meraz IM; Barbosa Rabago D; Kerr DL; Gomez C; Allegakoen DV; Guan J; Shah KN; Herrington KA; Gbenedio OM; Nanjo S; Majidi M; Tamaki W; Pourmoghadam YK; Rotow JK; McCoach CE; Riess JW; Gutkind JS; Tang TT; Post L; Huang B; Santisteban P; Goodarzi H; Bandyopadhyay S; Kuo CJ; Roose JP; Wu W; Blakely CM; Roth JA; Bivona TG
    Nat Commun; 2024 May; 15(1):3741. PubMed ID: 38702301
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Cytogenetic abnormalities and TP53 and RAS gene profiles of childhood acute lymphoblastic leukemia in Morocco.
    Skhoun H; El Fessikh M; El Alaoui Al Abdallaoui M; Khattab M; Belkhayat A; Chebihi ZT; Hassani A; Abilkassem R; Agadr A; Dakka N; El Baghdadi J
    Arch Pediatr; 2024 May; 31(4):238-244. PubMed ID: 38679547
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Proteogenomic Characterization Reveals Estrogen Signaling as a Target for Never-Smoker Lung Adenocarcinoma Patients without EGFR or ALK Alterations.
    Park SJ; Ju S; Goh SH; Yoon BH; Park JL; Kim JH; Lee S; Lee SJ; Kwon Y; Lee W; Park KC; Lee GK; Park SY; Kim S; Kim SY; Han JY; Lee C
    Cancer Res; 2024 May; 84(9):1491-1503. PubMed ID: 38607364
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The RAS-signaling-pathway-mutation-related prognosis in B-cell acute lymphoblastic leukemia: A report from South China children's leukemia group.
    Li X; Lin S; Liao N; Mai H; Long X; Liu L; Wu B; Chen Q; Kong Q; Kong X; Liu L; Qin J; Fang J; Zhou D
    Hematol Oncol; 2024 May; 42(3):e3265. PubMed ID: 38564328
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Nationwide data from comprehensive genomic profiling assays for detecting driver oncogenes in non-small cell lung cancer.
    Ishida M; Iwasaku M; Doi T; Ishikawa T; Tachibana Y; Sawada R; Ogura Y; Kawachi H; Katayama Y; Nishioka N; Morimoto K; Tokuda S; Yamada T; Takayama K
    Cancer Sci; 2024 May; 115(5):1656-1664. PubMed ID: 38450844
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Cascade Co
    Wang L; Wang T; Zhuo Y; Xu S; Liu H; Jiang X; Lu Z; Wang X; Rao H; Wu D; Wang Y; Feng B; Sun M
    J Colloid Interface Sci; 2024 May; 662():962-975. PubMed ID: 38382379
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Response of a Novel KANK1::ALK Fusion to Alectinib in an Advanced Lung Adenocarcinoma: A Case Report.
    Tang Q; Li T; Ren F; Li X; Cao W; Yu H; Mao F; Cao C; Zu L; Xu S
    J Natl Compr Canc Netw; 2024 Feb; 22(2):. PubMed ID: 38364363
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Histiocytic sarcoma following CAR T-cell therapy: a case report.
    An K; He Y; Tang Y; Gu X; Qian J; Li B
    Int J Hematol; 2024 Mar; 119(3):338-341. PubMed ID: 38294639
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Clinical and molecular biological characterization of patients with accelerated chronic lymphocytic leukemia].
    Zhou ZY; Dai LMJ; Sha YQ; Qiu TL; Qin SC; Miao Y; Xia Y; Wu W; Tang HN; Xu W; Li JY; Zhu HY
    Zhonghua Xue Ye Xue Za Zhi; 2023 Nov; 44(11):917-923. PubMed ID: 38185521
    [No Abstract]    [Full Text] [Related]  

  • 10. [Clinical Analysis of Infants with Acute Lymphoblastic Leukemia (18 cases)].
    Li KL; Xiong H; Li H; Wang Z; Chen Z; Yang L; Lu WJ; Qi SS; Sun M
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1670-1675. PubMed ID: 38071044
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Circulating lung cancer biomarkers: From translational research to clinical practice.
    Qian X; Meng QH
    Tumour Biol; 2024; 46(s1):S27-S33. PubMed ID: 37927289
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Illuminating (HTLV-1)-induced adult T-cell leukemia/lymphoma transcriptomic signature: A systems virology approach.
    Forghani-Ramandi MM; Mostafavi B; Bahavar A; Dehghankar M; Siami Z; Mozhgani SH
    Virus Res; 2023 Dec; 338():199237. PubMed ID: 37832654
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Sotorasib after immune checkpoint inhibitor administration induces hepatotoxicity. True, false or just another adverse effect of NSCLC treatment.
    Zarogoulidis P; Matthaios D; Oikonomou P; Nikolaou C; Charalampidis C; Sardeli C
    Cancer Treat Res Commun; 2023; 37():100757. PubMed ID: 37666686
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. SARS-CoV-2 intrahost evolution in immunocompromised patients in comparison with immunocompetent populations after treatment.
    Ahmadi AS; Zadheidar S; Sadeghi K; Nejati A; Salimi V; Hajiabdolbaghi M; Mokhtari-Azad T; Yavarian J
    J Med Virol; 2023 Jun; 95(6):e28877. PubMed ID: 37341553
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Identification of crucial genes involved in thyroid cancer development.
    Kalarani IB; Sivamani G; Veerabathiran R
    J Egypt Natl Canc Inst; 2023 May; 35(1):15. PubMed ID: 37211566
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Impact of
    Mustafa Ali MK; Williams MT; Corley EM; AlKaabba F; Niyongere S
    Leuk Lymphoma; 2023 May; 64(5):962-971. PubMed ID: 37042657
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Changes of tumor microenvironment in non-small cell lung cancer after TKI treatments.
    Chen S; Tang J; Liu F; Li W; Yan T; Shangguan D; Yang N; Liao D
    Front Immunol; 2023; 14():1094764. PubMed ID: 36949948
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Trends in Survival Rates of Non-Small Cell Lung Cancer With Use of Molecular Testing and Targeted Therapy in Korea, 2010-2020.
    Chi SA; Yu H; Choi YL; Park S; Sun JM; Lee SH; Ahn JS; Ahn MJ; Choi DH; Kim K; Jung HA; Park K
    JAMA Netw Open; 2023 Mar; 6(3):e232002. PubMed ID: 36929402
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Identification of Hub Genes Associated with Resistance to Prednisolone in Acute Lymphoblastic Leukemia Based on Weighted Gene Co-expression Network Analysis.
    Nekoeian S; Ferdowsian S; Asgari Y; Azizi Z
    Mol Biotechnol; 2023 Nov; 65(11):1913-1922. PubMed ID: 36877306
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Lung Cancer - Standard Therapy and the Use of a Novel, Highly Effective, Well Tolerated, treatment With Progesterone Receptor Modulators.
    Check JH; Poretta T; Check D; Srivastava M
    Anticancer Res; 2023 Mar; 43(3):951-965. PubMed ID: 36854512
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 14.